Furthermore, ARRB2 and PFKFB3 are promising biomarker candidates for Huntington’s disease (HD) due to their involvement in key pathological processes—ARRB2 in neuronal signaling and cell death, and PFKFB3 in glycolytic metabolism and energy stress. Here, PFKFB3 is linked to juvenile Huntington disease.